A wearable pregnancy monitoring device is being showcased at Medica by wearables manufacturer Nuvo Group.
The company’s PregSense devices used the internet of things to let expecting mothers capture data from both themselves and the foetus. The company hopes that the device will let doctors gain more insight into the condition of the pregnancy and result in a better experience for mothers.
The device is a non-invasive system that collects a wide range of pregnancy data that can then be sent directly to a patient’s physician or monitoring service. PregSense uses wireless electronic and acoustic sensors to passively collected data.
PregSense is aiming to gain FDA approval to be recognised as a class II device. If approved, physicians will be able to prescribe the device to review and analyse pregnancy data. Physicians will get an in-depth view of the pregnancy, giving them the ability to design personalised treatment protocols at critical stages of the pregnancy.
The system includes an app to allow parents to track and record important pregnancy milestones such as the baby’s first kick and kick frequency, upcoming doctor appointments, dietary recommendations and important lab results. Information can be viewed within the app’s Pregnancy Journal Dashboard.
Oren Oz, CEO of Nuvo Group, said: “PregSense transforms pregnancy healthcare, delivering real-time care at a lower cost. It’s the next major leap in remote healthcare, fulfilling a critical need for women who may not be able to get to the doctor as frequently due to location or finances.”